BARCLAYS PLC - CATABASIS PHARMACEUTICALS IN ownership

Back to all holdings Add to watchlist

CATABASIS PHARMACEUTICALS IN's ticker is and the CUSIP is 14875P206. A total of 53 filers reported holding CATABASIS PHARMACEUTICALS IN in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Links
Filings
Quarter-by-quarter ownership
BARCLAYS PLC ownership history of CATABASIS PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2021$11,000
-89.7%
5,311
-85.6%
0.00%–
Q1 2021$107,000
+87.7%
36,926
+39.2%
0.00%–
Q4 2020$57,000
+5.6%
26,534
+203.0%
0.00%–
Q3 2020$54,000
-15.6%
8,758
-11.7%
0.00%–
Q2 2020$64,000–9,913–0.00%–
 Download
Other shareholders

There were no reported owners of CATABASIS PHARMACEUTICALS IN in Q2 2020.

NameSharesValueWeighting ↓
View complete list of CATABASIS PHARMACEUTICALS IN shareholders